Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Quarterly results Director departure Appointed director
|
Enveric Biosciences, Inc. (AMRH)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
03/14/2023 |
4
| Coveney Kevin Michael (CFO) has filed a Form 4 on Enveric Biosciences, Inc.
Txns:
| Granted 26,500 shares
@ $0 |
|
03/14/2023 |
3
| Coveney Kevin Michael (CFO) has filed a Form 3 on Enveric Biosciences, Inc. |
01/27/2023 |
4
| Facchini Peter J. (Chief Innovation Officer) has filed a Form 4 on Enveric Biosciences, Inc.
Txns:
| Granted 17,000 shares
@ $0 |
|
01/27/2023 |
4
| Hagel Jillian Marie (Vice President of Innovation) has filed a Form 4 on Enveric Biosciences, Inc.
Txns:
| Granted 12,000 shares
@ $0 |
|
01/27/2023 |
4
| Kanubaddi Avani (President and COO) has filed a Form 4 on Enveric Biosciences, Inc.
Txns:
| Granted 10,000 shares
@ $0 |
|
01/27/2023 |
4
| Tucker Joseph Edward (CEO) has filed a Form 4 on Enveric Biosciences, Inc.
Txns:
| Granted 44,000 shares
@ $0 |
|
01/25/2023 |
4
| Hagel Jillian Marie (Chief Technology Officer) has filed a Form 4 on Enveric Biosciences, Inc.
Txns:
| Granted 1,021 shares
@ $0 Granted 10,500 shares
@ $0 |
|
01/25/2023 |
4
| Facchini Peter J. (Chief Scientific Officer) has filed a Form 4 on Enveric Biosciences, Inc.
Txns:
| Granted 1,021 shares
@ $0 Granted 10,500 shares
@ $0 |
|
01/25/2023 |
4
| Tucker Joseph Edward (CEO) has filed a Form 4 on Enveric Biosciences, Inc.
Txns:
| Granted 1,374 shares
@ $0 Granted 15,000 shares
@ $0 |
|
09/23/2022 |
3
| Dickey Robert IV (CFO) has filed a Form 3 on Enveric Biosciences, Inc. |
07/22/2022 |
3
| PASQUALONE FRANK (Director) has filed a Form 3 on Enveric Biosciences, Inc. |
07/05/2022 |
3
| O'NEIL BEVIN (Director) has filed a Form 3 on Enveric Biosciences, Inc. |
06/22/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
01/25/2022 |
4
| Ward Carter Julian (CFO) has filed a Form 4 on Enveric Biosciences, Inc.
Txns:
| Granted 744,429 options to buy
@ $0 |
|
01/25/2022 |
4
| Kanubaddi Avani (President and COO) has filed a Form 4 on Enveric Biosciences, Inc.
Txns:
| Granted 1,127,787 options to buy
@ $0 |
|
10/18/2021 |
4
| Hagel Jillian Marie (Chief Technology Officer) has filed a Form 4 on Enveric Biosciences, Inc.
Txns:
| Granted 82,398 shares
@ $0 Granted 531,602 shares
@ $0 Granted 99,675 options
@ $1.88, valued at
$187.4k
Granted 79,740 options to buy
@ $0.94, valued at
$75k
Granted 531,602 options to buy
@ $0.94, valued at
$499.7k
Granted 1,329 options to buy
@ $2.82, valued at
$3.7k
|
|
10/18/2021 |
3
| Hagel Jillian Marie (Chief Technical Officer) has filed a Form 3 on Enveric Biosciences, Inc. |
10/15/2021 |
4
| Facchini Peter J. (Chief Scientific Officer) has filed a Form 4 on Enveric Biosciences, Inc.
Txns:
| Granted 85,056 shares
@ $0 Granted 531,602 shares
@ $0 Granted 99,675 options
@ $1.88, valued at
$187.4k
Granted 79,740 options to buy
@ $0.94, valued at
$75k
Granted 531,602 options to buy
@ $0.94, valued at
$499.7k
Granted 2,658 options to buy
@ $2.82, valued at
$7.5k
|
|
10/15/2021 |
3
| Facchini Peter J. (Chief Scientific Officer) has filed a Form 3 on Enveric Biosciences, Inc. |
10/12/2021 |
4/A
| Tucker Joseph Edward (CEO) has filed a Form 4 on Enveric Biosciences, Inc.
Txns:
| Granted 691,083 shares
@ $0 Granted 132,901 options to buy
@ $0.94, valued at
$124.9k
Granted 531,602 options to buy
@ $0.94, valued at
$499.7k
Granted 13,290 options to buy
@ $2.82, valued at
$37.5k
|
|
09/27/2021 |
4
| Tucker Joseph Edward (CEO) has filed a Form 4 on Enveric Biosciences, Inc.
Txns:
| Granted 691,083 shares
@ $0 Granted 199,351 options
@ $1.88, valued at
$374.8k
Granted 664,503 options to buy
@ $0.94, valued at
$624.6k
Granted 13,290 options to buy
@ $2.82, valued at
$37.5k
|
|
09/27/2021 |
4
| Thompson Bradley George (Director) has filed a Form 4 on Enveric Biosciences, Inc.
Txns:
| Granted 53,160 options
@ $0.94, valued at
$50k
|
|
09/27/2021 |
3
| Tucker Joseph Edward (CEO) has filed a Form 3 on Enveric Biosciences, Inc. |
09/27/2021 |
3
| Thompson Bradley George (Director) has filed a Form 3 on Enveric Biosciences, Inc. |
05/27/2021 |
3
| Ward Carter Julian (CFO) has filed a Form 3 on Enveric Biosciences, Inc. |
04/02/2021 |
4
| LIND DOUGLAS (Director) has filed a Form 4 on Enveric Biosciences, Inc.
Txns:
| Granted 2,265 shares
@ $0 |
|
04/02/2021 |
3
| LIND DOUGLAS (Director) has filed a Form 3 on Enveric Biosciences, Inc. |
03/08/2021 |
4
| Van Buiten John (CFO) has filed a Form 4 on Enveric Biosciences, Inc.
Txns:
| Granted 25,000 shares
@ $0 |
|
02/17/2021 |
4
| Mayer Solomon (Director) has filed a Form 4 on Enveric Biosciences, Inc.
Txns:
| Granted 15,957 shares
@ $0 |
|
02/17/2021 |
4
| Kegler George A. (Director) has filed a Form 4 on Enveric Biosciences, Inc.
Txns:
| Granted 15,957 shares
@ $0 |
|
02/17/2021 |
4
| Schabacker Marcus (Director) has filed a Form 4 on Enveric Biosciences, Inc.
Txns:
| Granted 15,957 shares
@ $0 |
|
02/17/2021 |
4
| Johnson David Ian (CEO and Chairman) has filed a Form 4 on Enveric Biosciences, Inc.
Txns:
| Granted 1,315,807 restricted stock units
@ $0 Granted 53,192 restricted stock units
@ $0 |
|
02/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/08/2021 |
3
| TOP Invest LLC (10% Owner) has filed a Form 3 on Enveric Biosciences, Inc. |
|
|
|